Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Corvus Pharmaceuticals, Inc. (CRVS)
Sector: Healthcare; Industry: Biotechnology

Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. Its lead product candidate is CPI-444, an oral, small molecule antagonist of the A2A receptor that is in Phase I/Ib clinical trial for adenosine, an immune checkpoint.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-02-17 Thompson Peter A. 10%-Owner, Director Buy 1,285,714 $3.50 $4,499,999 No
2019-08-06 Thompson Peter A. 10%-Owner, Director Buy 142,656 $3.51 $500,723 No
2019-07-01 Thompson Peter A. 10%-Owner, Director Buy 657,344 $3.72 $2,444,065 No
2018-03-12 Thompson Peter A. 10%-Owner, Director Buy 588,235 $8.50 $4,999,998 No
2016-06-24 Thompson Peter A. 10%-Owner, Director Buy 1,000 $12.98 $12,983 No
2016-06-21 Thompson Peter A. 10%-Owner, Director Buy 38,383 $12.75 $489,192 No
2016-06-16 Thompson Peter A. 10%-Owner, Director Buy 20,000 $12.35 $247,000 No
2016-06-10 Thompson Peter A. 10%-Owner, Director Buy 50,000 $12.96 $648,100 No
2016-05-20 Thompson Peter A. 10%-Owner, Director Buy 4,716 $13.09 $61,732 No
2016-05-19 Thompson Peter A. 10%-Owner, Director Buy 6,800 $11.77 $80,035 No
2016-03-29 Thompson Peter A. 10%-Owner, Director Buy 550,000 $15.00 $8,250,000 Yes

Insider Smart

Camping World Holdings, Inc (CWH) - Another crash victim, Camping World Holdings, Inc took a deep dive from $16 to $4, several insiders bought around $6. With insiders on your side, this would be an easy add and hold to get your cost under $6. A 300% gain because stock is about to breach $25 in the coming weeks.